Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.2138 | 1 | 0.5 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.088 | 0.1084 | 0.0975 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.088 | 0.1084 | 0.1084 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.2138 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2138 | 1 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.2138 | 1 | 0.5 |
Schistosoma mansoni | patched 1 | 0.088 | 0.1084 | 0.1084 |
Echinococcus multilocularis | protein patched | 0.088 | 0.1084 | 0.0975 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.1003 | 0.1955 | 0.5 |
Echinococcus multilocularis | protein dispatched 1 | 0.088 | 0.1084 | 0.0975 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.2138 | 1 | 0.5 |
Echinococcus granulosus | Protein patched homolog 1 | 0.088 | 0.1084 | 0.0975 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.2138 | 1 | 1 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.2138 | 1 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1003 | 0.1955 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1003 | 0.1955 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0744 | 0.0121 | 0.0121 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.2138 | 1 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.088 | 0.1084 | 0.0975 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.2138 | 1 | 0.5 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.088 | 0.1084 | 0.0975 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.088 | 0.1084 | 0.0975 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1003 | 0.1955 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED150 (functional) | = 0.39 mg kg-1 | Effective dose against aconitine-induced arrhythmia after intravenal administration in anesthetized rats | ChEMBL. | 3806567 |
LD50 (ADMET) | = 2 mg kg-1 | Acute toxicity determined after intravenal administration in mice | ChEMBL. | 3806567 |
LD50 (ADMET) | = 2 mg kg-1 | Acute toxicity determined after intravenal administration in mice | ChEMBL. | 3806567 |
No. of positive cases (functional) | = 10 | Tested for incidence of arrhythmias in rats after a intravenal administration of 0.5 mg/kg of the compound expressed as no. of positive cases out of no. of tested cases (10) | ChEMBL. | 3806567 |
Relative potency (functional) | = 30.5 | Relative potency with reference to quinidine | ChEMBL. | 3806567 |
Therapeutic index (ADMET) | = 5.1 | Therapeutic index calculated as the ratio of LD50 in mice to ED 150 in rat when administered intravenously | ChEMBL. | 3806567 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.